Terms: = Pancreatic cancer AND REL, I-Rel, 5966, ENSG00000162924, C-Rel AND Treatment
12 results:
1. Comparison of outcomes of EUS-guided ablation and surveillance only for pancreatic cystic lesions: a propensity score-matching study (with videos).
Song YJ; Huh G; Kim EH; Lee JB; Park DH
Gastrointest Endosc; 2023 Oct; 98(4):585-596.e3. PubMed ID: 37211286
[TBL] [Abstract] [Full Text] [Related]
2. Patient-centered outcomes in the POLO study of active maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer.
Kindler HL; Yoo HK; Hettle R; Cui KY; Joo S; Locker GY; Golan T
Cancer; 2023 May; 129(9):1411-1418. PubMed ID: 36811344
[TBL] [Abstract] [Full Text] [Related]
3. Novel treatment strategy of targeting epigenetic dysregulation in pancreatic neuroendocrine tumors.
Zhu C; Sandilos G; Williamson J; Emery R; Platoff R; Joneja U; Acharya NK; Lin A; Badach J; Zilberman B; Madzo J; Jelinek J; Zhang P; Hong YK
Surgery; 2023 Apr; 173(4):1045-1051. PubMed ID: 36642656
[TBL] [Abstract] [Full Text] [Related]
4. A phase 1b trial of concurrent immunotherapy and irreversible electroporation in the treatment of locally advanced pancreatic adenocarcinoma.
O'Neill C; Hayat T; Hamm J; Healey M; Zheng Q; Li Y; Martin RCG
Surgery; 2020 Oct; 168(4):610-616. PubMed ID: 32631655
[TBL] [Abstract] [Full Text] [Related]
5. Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer.
Konczalla L; Perez DR; Wenzel N; Wolters-Eisfeld G; Klemp C; Lüddeke J; Wolski A; Landschulze D; Meier C; Buchholz A; Yao D; Hofmann BT; Graß JK; Spriestersbach SL; Grupp K; Schumacher U; Betzel C; Kapis S; Nuguid T; Steinberg P; Püschel K; Sauter G; Bockhorn M; Uzunoglu FG; Izbicki JR; Güngör C; El Gammal AT
Int J Cancer; 2020 Mar; 146(6):1618-1630. PubMed ID: 31291468
[TBL] [Abstract] [Full Text] [Related]
6. Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis.
Pelzer U; Blanc JF; Melisi D; Cubillo A; Von Hoff DD; Wang-Gillam A; Chen LT; Siveke JT; Wan Y; Solem CT; Botteman MF; Yang Y; de Jong FA; Hubner RA
Br J Cancer; 2017 May; 116(10):1247-1253. PubMed ID: 28350787
[TBL] [Abstract] [Full Text] [Related]
7. Evaluating TBK1 as a therapeutic target in cancers with activated IRF3.
Muvaffak A; Pan Q; Yan H; Fernandez R; Lim J; Dolinski B; Nguyen TT; Strack P; Wu S; Chung R; Zhang W; Hulton C; Ripley S; Hirsch H; Nagashima K; Wong KK; Jánne PA; Seidel-Dugan C; Zawel L; Kirschmeier PT; Middleton RE; Morris EJ; Wang Y
Mol Cancer Res; 2014 Jul; 12(7):1055-66. PubMed ID: 24752990
[TBL] [Abstract] [Full Text] [Related]
8. Quality-adjusted survival with combination nab-paclitaxel + gemcitabine vs gemcitabine alone in metastatic pancreatic cancer: a Q-TWiST analysis.
Reni M; Wan Y; Solem C; Whiting S; Ji X; Botteman M
J Med Econ; 2014 May; 17(5):338-46. PubMed ID: 24654922
[TBL] [Abstract] [Full Text] [Related]
9. The expression of the pro-apoptotic gene Air is inducible in human pancreatic adenocarcinoma cells.
d'Avenia M; Rosati A; Belisario MA; Torino M; Torino G; Turco MC; Pascale M
J Cell Physiol; 2011 Sep; 226(9):2207-12. PubMed ID: 21437899
[TBL] [Abstract] [Full Text] [Related]
10. Suppression of uPA and uPAR blocks radiation-induced MCP-1 mediated recruitment of endothelial cells in meningioma.
Nalla AK; Gogineni VR; Gupta R; Dinh DH; Rao JS
Cell Signal; 2011 Aug; 23(8):1299-310. PubMed ID: 21426933
[TBL] [Abstract] [Full Text] [Related]
11. Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells.
Srivastava SK; Singh SV
Carcinogenesis; 2004 Sep; 25(9):1701-9. PubMed ID: 15117814
[TBL] [Abstract] [Full Text] [Related]
12. NF-kappaB/rel transcriptional pathway: implications in pancreatic cancer.
Algül H; Adler G; Schmid RM
Int J Gastrointest Cancer; 2002; 31(1-3):71-8. PubMed ID: 12622417
[TBL] [Abstract] [Full Text] [Related]
